Refine by
Physiological Fluid Suppliers & Manufacturers
7 companies found
based inMedford, MASSACHUSETTS (USA)
ZefSci started with the vision that a complex LC-MS-MS environment requires a highly technical team with multi-disciplinary knowledge and a strong dedication to customers and their applications. This vision and our strong business ethic has led us ...
based inAbingdon, UNITED KINGDOM
Founded on innovation and operating with an entrepreneurial flair, Oxford Optronix is a global pioneer in design, development and manufacture of sophisticated instrumentation for the life sciences. Our products are designed, developed and ...
based inHennigsdorf, GERMANY
We are experts in water purification systems and related analysis equipment for 30 years. membraPure was founded over 30 years ago and is still run as a family business. Over the years, membraPure grew and we currently have 31 employees. Our ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
based inEresing, GERMANY
Sykam GmbH is a family-owned company based in Germany, serving customers around the world with chromatography equipment. With the extensive in-house R&D and manufacturing facilities Sykam has evolved into a highly regarded company by ...
The Sykam S 633 Amino Acid Analyzer is developed as a complete operational system completed with a series of ready to use buffers, reagents and columns for physiological fluids and food/feedstuff hydrolysate amino ...
based inLouviers, FRANCE
The story behind Stendo® is that of the meeting of two men who wanted to provide an answer to people seeking to improve their sense of well-being. Fascinated by technology, health, and driven by the goal of manufacturing in France, they pooled their ...
based inDevon, PENNSYLVANIA (USA)
At Zynerba Pharmaceuticals, our team is dedicated to developing next-generation transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. Often, these diseases have few, if any, ...